Publications by authors named "Anabel Ballesteros"

Claim this Profile
C
C-Peptide and BMi predict anti-hyperglycemic treatment lines in breast cancer patients treated with Alpelisib.
Elena Carrillo-Lopez, Fernando Sebastian-Valles, Carolina Sager La Ganga, Anabel Ballesteros, Victor Navas-Moreno

Endocrine· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Excess weight and anti-PD-1 immune checkpoint inhibitor's outcomes in non-small cell lung cancer.
Jacobo Rogado, Fernando Pozo, Kevin Troulé, José Miguel Sánchez-Torres, Nuria Romero-Laorden, Anabel Ballesteros

Clin Transl Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral Blood Mononuclear Cells Predict Therapeutic Efficacy of Immunotherapy in NSCLC.
Jacobo Rogado, Fernando Pozo, Kevin Troule, José Miguel Sánchez-Torres, Nuria Romero-Laorden, Anabel Ballesteros

Cancers (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dabrafenib plus trametinib for compassionate use in metastatic melanoma: A STROBE-compliant retrospective observational postauthorization study.
Salvador Martín Algarra, Virtudes Soriano, Luis Fernández-Morales, Miguel-Ángel Berciano-Guerrero, Karmele Mujika, Anabel Ballesteros

Medicine (Baltimore)· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2/neu testing for anti-HER2-based therapies in patients with unresectable and/or metastatic gastric cancer.
Carlos Gómez-Martin, Elena Garralda, M José Echarri, Anabel Ballesteros, Alberto Arcediano

J Clin Pathol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis